Every year, adverse drug events affect over 134 million patients and claim 2.4 million lives globally. But what if there was a faster, smarter way to predict and prevent these outcomes—before they happen?

Join us to discover QIAGEN Pharmacogenomic Insights (PGXI), a revolutionary tool built to help labs and pharmaceutical companies turn complex pharmacogenomics (PGx) data into clear, actionable insights—fast. PGXI delivers instant access to expertly curated, up-to-date information from trusted sources like the FDA, CPIC, DPWG, PharmVar, and PubMed, all in one seamless platform.

Proven through the annotation of more than 1.6 million PGx findings across 250+ labs, PGXI integrates effortlessly into any workflow, whether you're working with NGS, arrays, or hybrid models. In just minutes, you can confidently identify drug-gene associations, uncover conditions linked to critical variants, and access peer-reviewed evidence—all customized to your specific genes of interest.

Plus, if eligible, webinar attendees can try PGXI for free with an exclusive trial offer from QIAGEN. There’s an easier and faster way to translate PGx data into insights. Don’t miss this opportunity to elevate and transform your PGx program.